The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(Z)-2-(N-Methyl-5-bromoindol-3-ylmethylene)-4,6-dihydroxybenzofuran-3(2H)-one ID: ALA3921707
PubChem CID: 134139366
Max Phase: Preclinical
Molecular Formula: C18H12BrNO4
Molecular Weight: 386.20
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cn1cc(/C=C2\Oc3cc(O)cc(O)c3C2=O)c2cc(Br)ccc21
Standard InChI: InChI=1S/C18H12BrNO4/c1-20-8-9(12-5-10(19)2-3-13(12)20)4-16-18(23)17-14(22)6-11(21)7-15(17)24-16/h2-8,21-22H,1H3/b16-4-
Standard InChI Key: PDOGVBARESRHII-XRVIQIRUSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
13.5994 -13.0173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5981 -13.8448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3130 -14.2576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3112 -12.6046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0266 -13.0137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0315 -13.8448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8234 -14.0970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3080 -13.4218 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8155 -12.7523 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.8846 -12.6050 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.3120 -15.0827 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.0829 -14.8801 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.1331 -13.4169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6203 -12.7517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0390 -11.4833 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.3702 -11.9655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7042 -11.9706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4446 -12.7524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9913 -13.3660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7978 -13.1992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0546 -12.4133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5062 -11.8030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0422 -10.6584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3476 -13.8143 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 5 1 0
1 10 1 0
3 11 1 0
7 12 2 0
8 13 2 0
13 14 1 0
14 18 1 0
17 15 1 0
15 16 1 0
16 14 2 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
15 23 1 0
20 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 386.20Molecular Weight (Monoisotopic): 384.9950AlogP: 3.97#Rotatable Bonds: 1Polar Surface Area: 71.69Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.70CX Basic pKa: ┄CX LogP: 4.34CX LogD: 4.16Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.62Np Likeness Score: 0.02
References 1. Baiceanu E, Nguyen KA, Gonzalez-Lobato L, Nasr R, Baubichon-Cortay H, Loghin F, Le Borgne M, Chow L, Boumendjel A, Peuchmaur M, Falson P.. (2016) 2-Indolylmethylenebenzofuranones as first effective inhibitors of ABCC2., 122 [PMID:27393949 ] [10.1016/j.ejmech.2016.06.039 ] 2. Jedlitschky, G G and 5 more authors. 1997-10-01 ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2. [PMID:9355767 ]